225
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies

, , , , , , , ORCID Icon, , , , , , , , , , , , , , , , , , & show all
Pages 1770-1773 | Received 23 Oct 2020, Accepted 18 Jan 2021, Published online: 07 Feb 2021
 

Disclosure statement

J. B. M. received honoraria from Abbvie, Jazz Pharmaceuticals, and Astellas. S. D. B. received honoraria from Agios, Celgene, Forma Therapeutics, Abbvie, Astellas, Daichi, Novartis, Pfizer and Jazz Pharmaceuticals and has received research funding from Agios and Forma Therapeutics. C. M. received honoraria from Astellas. W. C. received personal fee from Qiagen. P. H. received honoraria from Novartis Pharma, Amgen and non-financial support from Novartis Pharma, Amgen, Celgene, Janssen-Cilag and Roche.

The other authors (J. P., B. S. P., J. E. M., S. C., S. K. H., F. S., F. P., C. W., M. L., A. B. A., O. B., O. C., C. C. L., S. C., C. B., V. S., N. A., P. F., R. B., J. C. M., I. P., and C. B. C.) declare no potential competing interests.

Additional information

Funding

Institut National du Cancer (Plbio 2017) and Association pour la Recherche sur le Cancer (PGA 2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.